| Financial Year |
March 31 2023 |
| Monetary Funds |
94,981,803.82 |
| Held-for-trading Financial Assets |
359,680,226.86 |
| Notes Receivable |
1,024,865.00 |
| Accounts Receivable |
79,722,476.39 |
| Advances to Suppliers |
9,918,797.38 |
| Other Receivables |
3,631,409.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
114,906,359.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,606,400.52 |
| Total Current Assets |
695,734,561.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,310,916.70 |
| Fixed Assetes |
232,813,829.91 |
| Under-construction Projects |
5,060,581.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
33,514,652.58 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,314,839.43 |
| Deferred Income Tax Assets |
14,126,811.91 |
| Other Non-Current Assets |
16,266,100.00 |
| Sub-Total of Non-Current Assets |
315,575,471.32 |
| Total Assets |
1,011,310,032.42 |
| Short-Term Loans |
30,009,166.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
37,124,496.09 |
| Accounts Payable |
48,489,442.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,789,461.12 |
| Taxes Payable |
11,573,743.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,349,340.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
975,047.86 |
| Sub-Total of Current Liabilities |
188,308,472.83 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,686,827.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,995,823.78 |
| Total Liabilities |
201,304,296.61 |
| Paid-In Capital(Or Share Stock) |
168,877,148.00 |
| Capital Surplus |
186,569,745.57 |
| Surplus Reserve |
72,093,311.38 |
| LESS:Treasury Stock |
10,370,085.90 |
| Undistributed Profits |
349,379,622.38 |
| Minority Stockholder's Interest |
43,462,981.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
766,542,754.67 |
| Owner's Equity（Stockholder's Equity） |
810,005,735.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,011,310,032.42 |
